Average Co-Inventor Count = 4.75
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novozymes, Inc. (13 from 384 patents)
2. Novozymes A/s (10 from 1,371 patents)
3. Ekso Bionics, Inc. (3 from 43 patents)
4. Novo Zymes North America, Inc (2 from 63 patents)
5. Novosymes, Inc. (1 from 1 patent)
17 patents:
1. 12331332 - GH61 variants and polynucleotides encoding same
2. 11891637 - GH61 polypeptide variants and polynucleotides encoding same
3. 11577410 - Control mechanisms and methods of tool-holding arm for exoskeletons
4. 11345905 - GH61 polypeptide variants and polynucleotides encoding same
5. 11085061 - Compositions comprising a GH61 polypeptide having cellulolytic enhancing activity and a liquor and method of using thereof
6. 10793845 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
7. 10351834 - GH61 polypeptide variants and polynucleotides encoding same
8. 10336993 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
9. 10327536 - Human exoskeleton devices for heavy tool support and use
10. 10316343 - Compositions comprising a polypeptide having cellulolytic enhancing activity and a liquor and uses thereof
11. 10245204 - Devices and methods for improving the utility of an exoskeleton mobility base
12. 10227579 - GH61 polypeptide variants and polynucleotides encoding same
13. 9994833 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
14. 9982285 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
15. 9816082 - Variants of polypeptides having cellulolytic enhancing activity and polynucleotides encoding same